122 related articles for article (PubMed ID: 11889190)
1. Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies.
Lefebvre H; Cartier D; Duparc C; Lihrmann I; Contesse V; Delarue C; Godin M; Fischmeister R; Vaudry H; Kuhn JM
J Clin Endocrinol Metab; 2002 Mar; 87(3):1211-6. PubMed ID: 11889190
[TBL] [Abstract][Full Text] [Related]
2. Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: in vivo and in vitro studies.
Contesse V; Reznik Y; Louiset E; Duparc C; Cartier D; Sicard F; Laquerriere A; Parmentier F; Kuhn JM; Vaudry H; Lefebvre H
J Clin Endocrinol Metab; 2005 May; 90(5):2843-50. PubMed ID: 15705918
[TBL] [Abstract][Full Text] [Related]
3. Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism.
Lefebvre H; Cartier D; Duparc C; Contesse V; Lihrmann I; Delarue C; Vaudry H; Fischmeister R; Kuhn JM
Endocr Res; 2000 Nov; 26(4):583-7. PubMed ID: 11196433
[TBL] [Abstract][Full Text] [Related]
4. The serotonin-4 receptor agonist cisapride and angiotensin-II exert additive effects on aldosterone secretion in normal man.
Lefebvre H; Contesse V; Delarue C; Legrand A; Kuhn JM; Vaudry H; Wolf LM
J Clin Endocrinol Metab; 1995 Feb; 80(2):504-7. PubMed ID: 7852511
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle.
Prins NH; Van Haselen JF; Lefebvre RA; Briejer MR; Akkermans LM; Schuurkes JA
Br J Pharmacol; 1999 Jul; 127(6):1431-7. PubMed ID: 10455293
[TBL] [Abstract][Full Text] [Related]
6. Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism.
Lefebvre H; Dhib M; Godin M; Contesse V; Delarue C; Rieu M; Wolf LM; Vaudry H; Kuhn JM
Neuroendocrinology; 1997 Sep; 66(3):229-33. PubMed ID: 9380281
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.
Louiset E; Isvi K; Gasc JM; Duparc C; Cauliez B; Laquerrière A; Kuhn JM; Lefebvre H
Endocr Relat Cancer; 2008 Dec; 15(4):1025-34. PubMed ID: 18708508
[TBL] [Abstract][Full Text] [Related]
8. Benzamide derivatives provide evidence for the involvement of a 5-HT4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells.
Idres S; Delarue C; Lefebvre H; Vaudry H
Brain Res Mol Brain Res; 1991 Jun; 10(3):251-8. PubMed ID: 1653392
[TBL] [Abstract][Full Text] [Related]
9. Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas.
Cartier D; Jégou S; Parmentier F; Lihrmann I; Louiset E; Kuhn JM; Bastard C; Plouin PF; Godin M; Vaudry H; Lefebvre H
Eur J Endocrinol; 2005 Dec; 153(6):939-47. PubMed ID: 16322401
[TBL] [Abstract][Full Text] [Related]
10. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies.
Lefebvre H; Contesse V; Delarue C; Soubrane C; Legrand A; Kuhn JM; Wolf LM; Vaudry H
J Clin Endocrinol Metab; 1993 Dec; 77(6):1662-6. PubMed ID: 8263156
[TBL] [Abstract][Full Text] [Related]
11. Effects of serotonin and vasopressin on cortisol production from an adrenocortical tumor causing subclinical Cushing's syndrome.
Contesse V; Reznik Y; Duparc C; Perraudin V; Vaudry H; Kuhn JM; Lefebvre H
Endocr Res; 2002 Nov; 28(4):787-91. PubMed ID: 12530699
[TBL] [Abstract][Full Text] [Related]
12. Inotropic effects of prokinetic agents with 5-HT(4) receptor agonist actions on human isolated myocardial trabeculae.
Chai W; Chan KY; de Vries R; van den Bogeardt AJ; de Maeyer JH; Schuurkes JA; Villalón CM; Saxena PR; Danser AH; MaassenVanDenBrink A
Life Sci; 2012 Apr; 90(13-14):538-44. PubMed ID: 22326501
[TBL] [Abstract][Full Text] [Related]
13. Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors.
Guillemot J; Compagnon P; Cartier D; Thouennon E; Bastard C; Lihrmann I; Pichon P; Thuillez C; Plouin PF; Bertherat J; Anouar Y; Kuhn JM; Yon L; Lefebvre H
Endocr Relat Cancer; 2009 Mar; 16(1):281-90. PubMed ID: 18948374
[TBL] [Abstract][Full Text] [Related]
14. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study.
Mannelli M; Ferruzzi P; Luciani P; Crescioli C; Buci L; Corona G; Serio M; Peri A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4616-22. PubMed ID: 14557431
[TBL] [Abstract][Full Text] [Related]
15. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
Contesse V; Hamel C; Lefebvre H; Dumuis A; Vaudry H; Delarue C
Mol Pharmacol; 1996 Mar; 49(3):481-93. PubMed ID: 8643088
[TBL] [Abstract][Full Text] [Related]
16. Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas.
Duparc C; Moreau L; Dzib JF; Boyer HG; Tetsi Nomigni M; Boutelet I; Boulkroun S; Mukai K; Benecke AG; Amar L; Gobet F; Meatchi T; Plouin PF; Zennaro MC; Louiset E; Lefebvre H
J Clin Endocrinol Metab; 2015 Apr; 100(4):E550-60. PubMed ID: 25599386
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic regulation of adrenocortical function.
Lefebvre H; Contesse V; Delarue C; Vaudry H; Kuhn JM
Horm Metab Res; 1998; 30(6-7):398-403. PubMed ID: 9694569
[TBL] [Abstract][Full Text] [Related]
18. 5-HT(4) receptors mediating enhancement of contractility in canine stomach; an in vitro and in vivo study.
Prins NH; van Der Grijn A; Lefebvre RA; Akkermans LM; Schuurkes JA
Br J Pharmacol; 2001 Apr; 132(8):1941-7. PubMed ID: 11309267
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome.
Cartier D; Lihrmann I; Parmentier F; Bastard C; Bertherat J; Caron P; Kuhn JM; Lacroix A; Tabarin A; Young J; Vaudry H; Lefebvre H
J Clin Endocrinol Metab; 2003 Jan; 88(1):248-54. PubMed ID: 12519861
[TBL] [Abstract][Full Text] [Related]
20. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
de Ridder WJ; Schuurkes JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
